Samsung has announced that he is first working to detect and monitor the left ventricular systolic discount (LVSD) in its smart watches in the world. It is a serious cardiovascular condition for about 50 % of all heart failure cases and is more deadly than some cancer.
In this way, initial detection is important to reduce the risk of death and reduce the risk of being hospitalized. The Korean Medical Device Company, which specializes in the Samsung AI -based ECG, will use the AI algorithm developed in partnership with Medical AI. The algorithm was developed on a 12 -lead ECG analysis based on Medical AI, which is already deployed to more than 100 larger Korean hospitals and is used for more than 120,000 patients a month.
This technology enables early screening for unmanageable people and aims to reduce health care costs associated with heart failure by promoting initial diagnosis and timely treatment.
Samsung has also contributed with Hanang University’s Department of Biomedical Engineering to produce an EEG prototype device, which aims to remove the limits of the traditional EEG system, which “a sleek, aergonomic design is presented out of the laboratory.” It receives high quality signals from the strategic electrode strategically placed around the mine.
The prototype provided “strong real -world application ability”, including real time to detect the accurate detection of drunkenness, and to identify participants’ video preferences in AI Brain View analysis, with 92.86 % accuracy, the latter “in the latter” neuromaving and leisure applications.
None of them have a date of release. LVSD detection and surveillance is clearly more solid technology, so we should see it in the real world at some point in the future.
Source
